CTRI/2011/11/002105
Completed
Phase 4
A comparative study on safety & efficacy of travoprost & brimonidine/timolol fixed combination in patients of primary open angle Glaucoma at ophthalmology department of Peoples College of Medical Sciences & Research Centre BhanpurBhopal.
nil0 sites70 target enrollmentTBD
ConditionsHealth Condition 1: null- glaucoma
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- glaucoma
- Sponsor
- nil
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •IOP in each eye more than 21 mm Hg.
- •Best corrected visual acuity 6/18 or better in each eye.
Exclusion Criteria
- •Progressive or functionally significant visual fields loss within past year.
- •Pregnant women or lactating mothers.
- •Patients with corneal abnormalities or any other conditions that prevent applanation tonometry.
- •Patients with ocular infection, advanced cataract, ocular inflammation.
- •Patients of bronchial asthma \& cardiac disease. Â
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
A Trial to compare the effect of two drug combinations Tolperisone with Etodolac and Thiocolchicoside with Etodolac in patients with low back pain and muscle spasmCTRI/2012/11/003159one200
Recruiting
Phase 2
Comparative study between the creams Ozenoxacin and Nadifloxacin in facial AcneCTRI/2024/01/061760ENDLURU SASIKALA
Not yet recruiting
Not Applicable
A Comparative Study on efficacy and safety of topical 2% clotrimazole cream daily twice application with oral fluconazole and topical 1% Piroctone olamine daily night application with oral fluconazole teice per week for total of 4 weeks in the treatment of extensive dermatophytosisHealth Condition 1: B354- Tinea corporisCTRI/2022/10/046904Department of DV
Not yet recruiting
Phase 4
Comparison study of effect of two concentrations of intra-lesional injection of a drug in patchy hair loss of the scalpHealth Condition 1: L639- Alopecia areata, unspecifiedCTRI/2022/11/047692I
Completed
Not Applicable
Comparative study of efficacy and safty of Travatanz and XalataglaucomaJPRN-UMIN000001874keio university school of medicine department of ophthalmology20